Recursion issues 102.3M shares to close Exscientia acquisition

RECURSION PHARMACEUTICALS, INC.

102,298,808 shares of Class A common stock issuable to Exscientia shareholders and option/RSU holders.
Shares issued in exchange for Exscientia ordinary shares and canceled equity awards under the Transaction Agreement.
Issuance exempt from registration under Securities Act Section 3(a)(10).
Transaction closed on November 20, 2024; this Amendment provides final share count.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.